| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium
Dendritic cells and macrophages are professional APCs that play a central role in initiating immune responses, linking innate and adaptive immunity. Chemerin is a novel chemoattractant factor that specifically attracts APCs through its receptor ChemR23. Interestingly, chemerin is secreted as a precursor of low biological activity, prochemerin, which upon proteolytic removal of a C-terminal peptide, is converted into a potent and highly specific agonist of its receptor. Given the fact that APCs are often preceded by polymorphonuclear cells (PMN) in inflammatory infiltrates, we hypothesized that PMN could mediate chemerin generation. We demonstrate here that human degranulated PMNs release proteases that efficiently convert prochemerin into active chemerin. The use of specific protease inhibitors allowed us to identify the neutrophil serine proteases cathepsin G and elastase as responsible for this process. Mass spectrometry analysis of processed prochemerin showed that each protease generates specifically a distinct form of active chemerin, differing in their C terminus and initially identified in human inflammatory fluids. These findings strongly suggest that bioactive chemerin generation takes place during the early stages of inflammation, underscoring the functional contribution of chemerin as a bridge between innate and adaptive immunity.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  S. Buonocore, N. O. Haddou, F. Moore, S. Florquin, F. Paulart, C. Heirman, K. Thielemans, M. Goldman, and V. Flamand Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L J. Leukoc. Biol., September 1, 2008; 84(3): 713 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Cash, R. Hart, A. Russ, J. P.C. Dixon, W. H. Colledge, J. Doran, A. G. Hendrick, M. B.L. Carlton, and D. R. Greaves Synthetic chemerin-derived peptides suppress inflammation through ChemR23 J. Exp. Med., April 14, 2008; 205(4): 767 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bozaoglu, K. Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, and D. Segal Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome Endocrinology, October 1, 2007; 148(10): 4687 - 4694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Goralski, T. C. McCarthy, E. A. Hanniman, B. A. Zabel, E. C. Butcher, S. D. Parlee, S. Muruganandan, and C. J. Sinal Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism J. Biol. Chem., September 21, 2007; 282(38): 28175 - 28188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Parolini, A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues Blood, May 1, 2007; 109(9): 3625 - 3632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kulig, B. A. Zabel, G. Dubin, S. J. Allen, T. Ohyama, J. Potempa, T. M. Handel, E. C. Butcher, and J. Cichy Staphylococcus aureus-Derived Staphopain B, a Potent Cysteine Protease Activator of Plasma Chemerin J. Immunol., March 15, 2007; 178(6): 3713 - 3720. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
